Health Media Articles

Excerpts of Key Health Media Articles in Major Media

Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.

Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

MDMA, the principal ingredient in the party drug ecstasy, is about to give a lifeline to some of the worst sufferers of post-traumatic stress disorder (PTSD) in Israel. The U.S. could be just years behind in launching similar clinical treatments using the substance. Israel’s Ministry of Health has approved the use of MDMA, a psychoactive drug, for use on dozens of patients. While the drug is still on the country’s law books as dangerous for recreational use, it is now being administered as treatment for compassionate use. In compassionate cases the drug will be made available to patients outside of clinical trials if they have not responded sufficiently to other medications or treatments. MDMA makes people feel euphoric, a sensation that made its use synonymous with rave culture and EDM (Electronic Dance Music), because it floods the body with serotonin. Serotonin is produced by nerve cells. When levels are low it can lead to depression and disrupt other physiological processes. The launching of the new Israeli initiative is a direct result of groundbreaking research in the U.S. The Middle Eastern nation approved the program after sending a representative to the California-based Multidisciplinary Association for Psychedelic Studies (MAPS) for training. MDMA has been illegal in the U.S. since 1985 but the findings of clinical trials, ongoing with Food and Drug Administration (FDA) approval since 2001, have shown that the drug enhances the treatment of PTSD in a clinical setting.

Note: Read also a CBC article titled "How psychedelic drugs are changing lives and transforming psychiatry." For more along these lines, see concise summaries of deeply revealing mind altering drugs news articles from reliable major media sources.

When Will Schuller was an 18-year-old senior in high school in Overland Park, Kansas, something puzzling was happening. He was “big into running at the time” and seemingly in good health, but ...Will struggled to walk from the school parking lot to his classes, and he couldn’t exercise. Around Christmas 2014, Will was diagnosed with Lambert-Eaton Myasthenic Syndrome (LEMS), a rare neuromuscular disorder. LEMS is “a chronic autoimmune disorder that affects strength and muscle fatigue ability,” said Dr. Ted M. Burns, a professor of neurology. There is a drug to treat LEMS that up until recently was free for patients through an FDA program called “compassionate use.” When Schuller got the drug, called ... 3,4-DAP, he instantly felt better. Since 1992, 3,4-DAP, was made by Jacobus Pharmaceuticals, a small New Jersey company, until a different company, Catalyst, recently received the exclusive rights to the drug. Catalyst added a preservative, renamed it Firdapse, and is now charging north of $375,000 a year for the life-changing drug. Will's parents said doctors ... warned them about an impending price increase, but they never imagined it would start costing hundreds of thousands of dollars. “We're paying ... less than that,” said Bob Schuller, Will’s dad. “But everyone's premiums are going to go up as a result of this. So it's a cost to the entire system.” Sen. Bernie Sanders, I-Vt., sent a letter to Catalyst on Monday demanding an explanation for the new price of Firdapse, calling it "a blatant fleecing of American taxpayers."

Note: Read how a major drug price increase nearly bankrupted the city of Rockford, Illinois. For more along these lines, see concise summaries of deeply revealing Big Pharma corruption news articles from reliable major media sources.

U.S. Senator Bernie Sanders plans to send a letter to Catalyst Pharmaceuticals on Monday asking it to justify its decision to charge $375,000 annually for a medication that for years has been available to patients for free. The drug, Firdapse, is used to treat Lambert-Eaton Myasthenic Syndrome (LEMS), a rare neuromuscular disorder. The disorder affects about one in 100,000 people in the United States. The government is intensifying its scrutiny of the pharmaceutical industry and rising prescription drug prices. Both the Democratic-led U.S. House of Representatives and the Senate, controlled by Republicans, have begun holding hearings this year on the rising costs of medicines. In the letter dated Feb. 4, Sanders asked Catalyst to lay out the financial and non-financial factors that led the company to set the list price at $375,000, and say how many patients would suffer or die as a result of the price and how much it was paying to purchase or produce the drug. For years, patients have been able to get Firdapse for free ... through a U.S. Food and Drug Administration (FDA) program called "compassionate use." The program allows patients with rare diseases and conditions access to experimental drugs outside of a clinical trial when there is no viable alternative. Florida-based Catalyst received FDA approval of Firdapse in November, along with exclusive rights to market the medication for several years. In December, Catalyst announced it would price Firdapse at $375,000 a year.

Note: Read how a major drug price increase nearly bankrupted the city of Rockford, Illinois. For more along these lines, see concise summaries of deeply revealing Big Pharma corruption news articles from reliable major media sources.

Pharmaceutical giant Purdue Pharma LP secretly pursued a plan, dubbed "Project Tango," to become "an end-to-end pain provider" by selling both opioids and drugs to treat opioid addiction, all while owners on the board - members of one of America's richest families - reaped more than $4 billion in opioid profits, according to a lawsuit newly unredacted. The suit says the company and its owners, the Sackler family ... engaged in a decade of deception to push their pharmaceuticals, namely the painkiller OxyContin, on doctors and patients, publicly denying what internal documents show they privately knew to be true: that the highly addictive drugs were resulting in overdoses and deaths. Purdue examined selling overdose antidotes, including Narcan, as "complementary" products to the same doctors to whom it sold its opioids, the lawsuit claims, and although the company maintained a ledger of doctors it suspected of inappropriate opioid prescriptions and other forms of abuse, dubbed "Region Zero," it continued to collect revenue from those doctors. The Sacklers paid themselves more than $4 billion in opioid profits between April 2008 and 2018. In 2017, there were 47,600 opioid-linked drug fatalities in the United States. The unredacted complaint also says consulting firm McKinsey & Co. played a crucial role in advising the company on how to push its product on doctors and boost its profits.

Note: Many doctors also profited from excessive prescribing of dangerous opioids. And according to a former DEA agent, Congress helped drug companies fuel the opioid epidemic. For more along these lines, see concise summaries of deeply revealing Big Pharma corruption news articles from reliable major media sources.

A small team of Israeli scientists is telling the world they will have the first “complete cure” for cancer within a year, The Jerusalem Post reported. And not only that, but they claim it will be brief, cheap and effective and will have no or minimal side-effects. “We believe we will offer in a year’s time a complete cure for cancer,” said Dan Aridor, chairman of the board of Accelerated Evolution Biotechnologies Ltd. (AEBi), a company founded in 2000 in ... Ness Ziona, Israel. A development-stage biopharmaceutical company engaged in discovery and development of therapeutic peptides, AEBi developed the SoAP platform, a combinatorial biology screening platform technology, which provides functional leads—agonist, antagonist, inhibitor, etc. - to very difficult targets. Called MuTaTo (multi-target toxin), researchers said the drug is essentially "on the scale of a cancer antibiotic a disruption technology of the highest order." Aridor told The Jerusalem Post: “Our cancer cure will be effective from day one, will last a duration of a few weeks and will have no or minimal side-effects at a much lower cost than most other treatments on the market. Our solution will be both generic and personal.” Currently in development ... the potential game-changer in the world-wide fight against cancer will use a combination of cancer-targeting peptides and a toxin that will specifically kill cancer cells. Every sixth death in the world is due to cancer, making it the second leading cause of death, second only to cardiovascular disease.

Note: Yet even in this article the attacks on these scientists have already begun. The cancer industry does not want to lose literally billions of dollars in profits. For more on this, see the Royal Rife story. For more along these lines, see concise summaries of deeply revealing major media news articles on other cancer treatments with high promise which were suppressed.

The lobbying group for the pharmaceutical industry spent about $27.5 million on lobbying activities in 2018, federal filings show. This is a record annual total for the Pharmaceutical Research & Manufacturers of America, or PhRMA, which represents most of the nation's largest drug and biopharmaceutical research companies. According to OpenSecrets, a nonpartisan, independent research group tracking money in US politics, individual companies within the pharmaceuticals and health products sector spent $194.3 million on lobbying as of October 24, 2018 over and above the amount disclosed by PhRMA.The large outlays follow moves within the White House that could limit pharmaceutical companies' price increases and profits on medicines. Congress and the Trump administration continue to push for a drug pricing plan and were given more ammunition Tuesday in the form of a report documenting that insulin cost nearly doubled in the United States between 2012 and 2016. President 'Donald Trump, who campaigned on a promise to lower drug prices, posted his blueprint for doing so in May. US Health and Human Services Secretary Alex Azar remarked last week that despite some "positive developments" in pharmaceutical pricing behavior, "drug companies have a lot further to go."

Note: For more along these lines, see concise summaries of deeply revealing news articles on pharmaceutical corruption from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.

Having a doctor who is warm and reassuring actually improves your health. The simple things a doctor says and does to connect with patients can make a difference for health outcomes. Even a brief reassurance to a patient from a doctor might relieve the patient’s symptoms faster. In a recent study ... our research group recruited 76 participants to receive a skin prick test, a common procedure used in assessing allergies. The provider in this study pricked participants’ forearms with histamine, which makes skin itchy and red. Then, the doctor examined the allergic reactions. For some patients, the doctor examined them without saying much. But for other patients, the doctor had some words of encouragement. He told them: “From this point forward, your allergic reaction will start to diminish, and your rash and irritation will go away.” It turns out that this one sentence of assurance from a provider led patients to report that their reactions were less itchy — even though the doctor didn’t give any medication or treatment along with his words. We often think the only parts of medical care that really matter are the “active” ingredients of medicine: the diagnosis, prognosis and treatment. But focusing only on these ingredients leaves important components of care underappreciated and underutilized. To really help people flourish, health care works better when it includes caring.

Note: The above was written by Stanford University psychologists Lauren Howe and Kari Leibowitz. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

A leading cancer expert, who was described as a "pioneer" in his field by Prince William, has died suddenly after receiving a routine yellow fever vaccination. Martin Gore, 67, died Thursday morning after receiving the vaccine. Professor Mel Greaves from the Institute of Cancer Research, described Gore as "a force of nature, very energetic, clear-thinking and compassionate." Gore's death casts light on the heightened risk associated with the yellow fever vaccine and the over-60 demographic. Typical side effects of the vaccine include headaches, muscle pain, mild fever and soreness at the injection site, according to the NHS. However, the vaccinations can, in rare circumstances, cause more severe side effects, including allergic reactions and problems affecting the brain or organs. The NHS estimates that these reactions occur less than 10 times for every million doses. The WHO reported that all cases of viscerotropic disease -- a rare but dangerous side effect of yellow fever vaccinations where an illness similar to wild-type yellow fever proliferates in multiple organs -- have occurred in primary vaccines, starting two to five days after vaccination. The Centers for Disease Control and Prevention -- the US government's health protection agency -- warns that viscerotropic disease can lead to multiple organ dysfunction syndrome or multi-organ failure and death in close to 60% of cases.

Note: For more along these lines, see concise summaries of deeply revealing news articles on vaccine safety from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.

Drug makers and other healthcare companies spent almost $30 billion in a single year to influence the medical choices made by Americans and steer them toward treatments that were newer, vastly more expensive and sometimes riskier than their tried-and-true alternatives, new research shows. The 2016 expenditures paid for TV commercials, sponsorships of patients' groups, promotional meetings for doctors, free drug samples and perks for prescribers. The amount represents a 70% increase since 1997, when drug companies began making direct appeals to American consumers. The study ... offers the most comprehensive accounting of healthcare marketing efforts to date. It traces broad shifts in the media and regulatory environment in which health companies operate, as well as the drugs and services – including erectile dysfunction pills, DNA testing kits and robotic surgery services – they are keen to sell. While lawmakers and regulators have tried to counter the impact of healthcare marketing in recent years, the reforms have had little effect on an industry that accounts for nearly 18% of the country's gross domestic product. The drug industry has increasingly turned to a more indirect approach in its marketing: sponsoring disease-awareness campaigns. Such campaigns, in which a company sponsors ads that do not name a particular medication, rose from 44 in 1997 to 401 in 2016, with an attendant spending increase from $177 million to $430 million.

Note: The pharmaceutical industry provides 75% of television advertising revenue when many countries do not allow drug advertising. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma profiteering from reliable major media sources.

Cancer is the second-leading cause of death among Americans, behind only heart disease. But there’s good news: the cancer death rate has drastically declined over the past 25 years, according to a new report from the American Cancer Society (ACS). Overall, the cancer death rate dropped by 27% between 1991 and 2016, according to the report’s data, which came from the National Center for Health Statistics. Steadily declining cancer mortality rates saved about 2.6 million lives between 1991 and 2016. Significant reductions in lung cancer mortality explain a large part of the overall trend. Smoking rates have fallen dramatically in recent years, corresponding to a significant dip in lung cancer deaths. And since smoking rates have traditionally been higher among men than women, male death rates have fallen especially far: by 48% between 1990 and 2016, compared to a 23% drop among women between 2002 and 2016. Racial gaps in cancer mortality are narrowing. But black Americans were still about 14% more likely to die from cancer than white Americans in 2016. That’s a sizable drop from 25 years ago, when the difference was 33%, but it still reflects the “inequalities in wealth that lead to differences in risk factor exposures and barriers to high-quality cancer prevention, early detection, and treatment,” the authors write.

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

The global insulin market is dominated by three companies: Eli Lilly, the French company Sanofi and the Danish firm Novo Nordisk. All three have raised list prices to similar levels. According to IBM Watson Health data, Sanofi’s popular insulin brand Lantus was $35 a vial when it was introduced in 2001; it’s now $270. Novo Nordisk’s Novolog was priced at $40 in 2001, and as of July 2018, it’s $289. The companies appear to have increased [prices] in lockstep over a number of years, prompting allegations of price fixing. All three companies denied these charges. (In 2010, Mexico fined Eli Lilly and three Mexican companies for price collusion on insulin, an allegation Eli Lilly also denied.) In the United States, a federal prosecutor and at least five state attorneys general are currently investigating the companies’ pricing practices. There is also another, less known corporate entity in the mix: pharmacy benefit managers (PBMs), which include Express Scripts, OptumRx and CVS Health; all are now named in lawsuits on high insulin prices. These corporate entities are powerful special interests. In 2017, the pharmaceutical and health product industry ... spent nearly $280 million on lobbying, the biggest spender by far of 20 top industries, according to the Center for Responsive Politics. The industry also has a revolving door to government. Alex Azar, the head of the Department of Health and Human Services, was the president of Eli Lilly’s U.S. division until 2017.

Note: For more along these lines, see concise summaries of deeply revealing news articles on pharmaceutical industry corruption from reliable major media sources.

Chickens slowly freezing to death, being boiled alive, drowned or suffocating under piles of other birds are among hundreds of shocking welfare incidents recorded at US slaughterhouses, according to previously unpublished reports. An investigation by the Guardian and the Bureau of Investigative Journalism looked at hundreds of inspection logs from the USDA detailing incidents in poultry plants across the country. Inspectors recorded numerous incidents where: chickens suffocated to death beneath other chickens when they piled up on a conveyor belt that had stopped due to a mechanical failure; chickens drowned after entering the scalding tank while conscious; thousands of birds died of heat stress ... or alternatively, freezing to death. In one incident in January, more than 34,000 chickens froze to death while being kept overnight outside a slaughterhouse in a truck. The ... findings have fuelled concerns that a post-Brexit trade deal with the US could see the UK flooded with chicken produced to lower welfare standards. This follows last year’s transatlantic row over chlorinated chicken, which prompted political interventions in both countries. The violations were witnessed between 2014 and this year at some of the largest poultry processors in the country as part of the national inspection system.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in the food system.

Teen vaping is reaching new heights of popularity, while underage drinking is plummeting to historic lows, according to new data from the 2018 Monitoring the Future survey. [National Institute on Drug Abuse] Director Dr. Nora Volkow says those record-setting peaks and valleys aren’t necessarily related. Volkow says the sleek designs of many top e-cigarette brands are also uniquely appealing to a generation that grew up surrounded by devices. “The new generation, their brain has developed to embrace these technologies,” Volkow says. “There is a massive change in culture that may be contributing to decreases in alcohol drinking, particularly heavy alcohol drinking,” Volkow says. “Many more teenagers interact through social media as opposed to interacting physically with one another. Taking drugs is a social behavior. By decreasing the opportunity that teenagers have of being face to face with one another, you may be decreasing the total exposure to these drugs,” including alcohol. Perhaps for some of the same reasons, other research has shown that teen sex is also on a downward trend. Tobacco use is also as low as it’s ever been, with just 3.6% of high school seniors reporting smoking daily. Aside from vaping, marijuana use was one of the only substance categories that did not decline in this year’s survey. Still, the survey results are largely encouraging for public health, with the exception of the rapidly rising vaping rates.

Note: For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources.

Near Tampa Bay, Florida, I watched airboats move up and down the river banks, spraying massive plumes of weedkiller. The main active ingredient in that mist ... is glyphosate. It is now an ingredient in more than 750 products, including ... Monsanto’s Roundup. This August, the jury in a civil trial found Monsanto, which was acquired [by] Bayer, guilty of causing the cancer of Dewayne Johnson, a school groundskeeper. Roughly 8,700 similar cases against Monsanto are also before the courts. Almonds, carrots, quinoa, soy products, vegetable oil, corn and corn oil, canola seeds used in canola oil, beets and beet sugar, sweet potatoes – these are just some of the foodstuffs which typically contain high levels of glyphosate. Research released in August by the non-profit Environmental Working Group (EWG) found that Cheerios, Quaker Old Fashioned Oats and at least 29 other popular breakfast foods contained what the EWG considers unsafe quantities of the herbicide. The environmental group has been urging public action to get the EPA to revise its outdated standards, which currently fail to protect the public from glyphosate in foods. Levels of glyphosate in the bodies of people in some areas appear to have jumped over 1,300% in the past 20 years. Unlike pharmaceuticals, which have to go through relatively rigorous (if imperfect) testing before being released on the marketplace, the vast majority of chemicals like glyphosate will never be adequately tested for their effects on ecosystems or human beings.

Note: The above article was written by activist Erin Brockovich. For more along these lines, see concise summaries of deeply revealing news articles on food system corruption and health.

The vaccine-skeptic Italian government has sacked every member of the country’s health advisory board. Health minister Giulia Grillo removed all 30 members of the Higher Health Council Monday, arguing it is time to “give space to the new.” The council is the country’s most prominent body of technical-scientific experts, who advise the government on health policy. Grillo is a member of the Five Star Movement (MS5)—the senior party in Italy’s ruling coalition, which has previously supported unproven cures for cancer and promised to overturn laws making vaccines mandatory for children. Explaining her decision, Grillo wrote on Facebook, “We are the #governmentofchange and, as I have already done with the appointments of the various organs and committees of the ministry, I have chosen to open the door to other deserving personalities.” MS5 came to power earlier this year on a wave of anti-establishment sentiment. The party’s vaccine-skepticism has also been well-publicized. During this year’s election campaign, MS5 promised to reform a law that made 10 vaccines mandatory and required a doctor’s note to confirm the injections. In June, Grillo said parents could “self-certify” that their children had been vaccinated and waved the requirement for doctor confirmation.

Note: An Italian court awarded 174,000 Euros to a family whose son was found to have developed autism from an MMR vaccine. Robert F. Kennedy, Jr. wrote an excellent, highly revealing article on the severe manipulations around vaccines. And don't miss an excellent study showing that nanoparticles of unknown nature are being found in vaccines. For more along these lines, see concise summaries of deeply revealing news articles on the risks of vaccines from reliable major media sources.

Last March, Tony Schmidt discovered something unsettling about the machine that helps him breathe at night. Without his knowledge, it was spying on him. From his bedside, the device was tracking when he was using it and sending the information not just to his doctor, but to the maker of the machine, to the medical supply company that provided it and to his health insurer. Schmidt, an information technology specialist ... was shocked. "I had no idea they were sending my information across the wire." Like millions of people, he relies on a continuous positive airway pressure, or CPAP, machine that streams warm air into his nose while he sleeps. Without it, Schmidt would wake up hundreds of times a night. As many CPAP users discover, the life-altering device comes with caveats: Health insurance companies are often tracking whether patients use them. If they aren't, the insurers might not cover the machines or the supplies that go with them. And, faced with the popularity of CPAPs ... and their need for replacement filters, face masks and hoses, health insurers have deployed a host of tactics that can make the therapy more expensive or even price it out of reach. A host of devices now gather data about patients, including insertable heart monitors and blood glucose meters. Privacy laws have lagged behind this new technology, and patients may be surprised to learn how little control they have over how the data is used or with whom it is shared.

Note: For more along these lines, see concise summaries of deeply revealing news articles on health and the disappearance of privacy.

Dead Dog on the Left isn’t just a documentary about the use of ecstasy in treating PTSD, it’s a story of the lengths one former marine will go to for friendship. [Tyler] McCourry and [Nigel] Flanigan are the subjects of [the] mini-documentary taken from a forthcoming feature film, MDMA the Movie, which explores the history of the so-called “party drug” more popularly known as ecstasy, its use in therapy, and harm reduction. Both films are directed by Emanuel Sferios. His protagonists may have survived the Iraq war, but only barely. Suicidal thoughts have stalked them both. In May 2012 McCourry did his first [MDMA-assisted psychotherapy] session ... lying in bed, flanked by two therapists. At the beginning of the session he was given a 75mg dose of MDMA. “During those eight hours you’re addressing the most challenging situations in your life,” he says. “It feels very exhausting, like it was some of the most work you’ve ever done in one day.” McCourry calls those trials, now completed, “a transformation of the psyche”. MDMA-assisted psychotherapy has “breakthrough therapy” designation by the FDA. “Since the MDMA therapy I’m able to recognise when something comes up that I need to talk about,” [McCourry] says. McCourry hopes that the therapy will be adopted by the Veterans Administration and Department of Defense. “If you can cure PTSD after three sessions of MDMA therapy then you don’t have to provide a veteran with medications for the rest of their life and talk therapy once a month.”

Note: A touching 26-documentary on this case is available at the above link. Articles like this suggest that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.

Spending hours on smartphones and tablet devices has frequently been linked to exacerbating mental wellbeing, but new research claims the damage might start in users as young as two. After just one hour of screen time, children and adolescents may have less curiosity, lower self-control and lower emotional stability, which can lead to an increased risk of anxiety and depression, claims a US study published in the journal Preventive Medicine Reports. The researchers found that those aged 14 to 17 are more at risk for such adverse effects, but noticed the correlations in younger children and toddlers, whose brains are still developing, as well. The study found that nursery school children who used screens frequently were twice as likely to lose their temper. It also claimed that nine per cent of those aged 11 to 13 who spent an hour a day on screens were not curious in learning new things, a figure which rose to 22.6 per cent for those whose screen time was seven hours a day or more. Authors Professor Jean Twenge, of San Diego State University, and Professor Keith Campbell, of the University of Georgia, said: "Half of mental health problems develop by adolescence. "Thus, there is an acute need to identify factors linked to mental health issues that are amenable to intervention in this population, as most antecedents are difficult or impossible to influence. "Compared to these more intractable antecedents of mental health, how children and adolescents spend their leisure time is more amenable to change."

Note: For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.

Yoga and meditation have increased in use among both U.S. adults and children in recent years, two new reports from the Centers for Disease Control and Prevention show, with the number of adults who had recently practiced yoga soaring by nearly 60 percent. In 2017, an estimated 35.2 million adults had put themselves in a downward-facing dog, lotus pose or other yoga position in the past 12 months, accounting for a 14.3 percent population share and up from 22.4 million (9.5 percent) in 2012. Women and adults between 18 and 44 were most likely to have recently practiced yoga in 2017. Meanwhile, a separate CDC report showed that the shares of children ages 4 to 17 who had practiced yoga or meditation each increased substantially. In 2012, an estimated 3.1 percent of children had done yoga in the past 12 months, compared with 8.4 percent in 2017. The estimated share of kids who had meditated recently increased nearly tenfold during that time frame, from 0.6 percent to 5.4 percent. "An increase in promoting yoga or promoting meditation in studios, gyms, et cetera, could play a role in ... more people using these approaches," says Tainya Clarke, an epidemiologist with the CDC's National Center for Health Statistics. Outpacing meditation and use of a chiropractor, yoga remained the most commonly used of the three "complementary health approaches" that were assessed. Still, the share who had meditated in the last year more than tripled between 2012 and 2017, from 4.1 percent to 14.2 percent.

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

This week, life sciences company COMPASS Pathways announced that it has received “Breakthrough Therapy” designation from the United States Food and Drug Administration for its psilocybin therapy aimed at individuals with treatment-resistant depression. Psilocybin, the main active ingredient in psychedelic mushrooms ... can alter one’s perception, thoughts and feelings or cause hallucinations. Researchers from Switzerland, the United Kingdom and the U.S. have been studying the therapy for many years. In fact, a study published in January found that the psychoactive compound helped revive emotional responsiveness in patients with treatment-resistant depression. Another showed that patients’ mental benefits after two psilocybin treatments lasted for weeks. COMPASS Pathways will begin running the first large-scale psilocybin clinical trial for treatment-resistant depression in Europe and North America within the next two years. "This is great news for patients,” COMPASS executive chairman George Goldsmith said. “We are excited to be taking this work forward with our clinical trial. The FDA will be working closely with us to expedite the development process and increase the chances of getting this treatment to people suffering with depression as quickly as possible.” While treatments such as antidepressants and psychotherapy exist, those with severe, treatment-resistant depression ... have trouble finding help. Approximately 100 million around the globe are affected by such treatment-resistant depression.

Note: In 2017, the psychoactive drug MDMA similarly received a "Breakthrough Therapy" designation from the FDA for the promise it shows in treating PTSD. Articles like this suggest that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.

Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.